Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$4.16M-$4.16MderivedN/M vs Q4 2020 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$3,939,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,624,000N/M ended Dec 31, 2021 · filed Feb 24, 2022 · 55 d after period end